- £220.85m
- £416.86m
- £371.52m
- 73
- 86
- 72
- 92
2019 March 31st | 2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 383 | 363 | 308 | 351 | 372 |
Cost of Revenue | |||||
Gross Profit | 87.3 | 70.2 | 48.1 | 89 | 87.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 345 | 326 | 303 | 308 | 332 |
Operating Profit | 38.3 | 37.2 | 5.48 | 43 | 39.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 33.6 | 28.4 | -2.27 | 35.6 | 30.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 25.8 | 18.6 | -4.6 | 25.5 | 23 |
Net Income Before Extraordinary Items | |||||
Net Income | 25.8 | 18.6 | -4.6 | 25.5 | 23 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 25.8 | 18.6 | -4.6 | 25.5 | 23 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.669 | 0.486 | -0.01 | 0.638 | 0.672 |
Dividends per Share | |||||
Special Dividends per Share |